GVR Report cover Medical Image Report

Medical Image Analysis Software Market Size, Share & Trends Analysis Report By End Use (Hospitals, ASC), By Software Type (Integrated, Standalone), By Imaging Type (3D, 4D), By Modality, By Application, And Segment Forecasts, 2022 - 2030

  • Report ID: 978-1-68038-918-0
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Report Overview

The global medical image analysis software market size was valued at USD 2.90 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.5% over the forecast period. A rise in demand for diagnostic imaging software in fields, such as dental, orthopedics, urology, neurology, and oncology, is likely to contribute to the market growth. The growing adoption of ultrasound imaging systems to facilitate faster diagnosis, particularly of chronic diseases, is expected to propel the demand. In addition, continuous developments in the field of imaging technology, such as Computer-aided Diagnosis (CAD), are anticipated to bolster the demand for these platforms. The introduction of Artificial Intelligence (AI) in medical imaging has changed the market dynamics in recent years and is anticipated to positively influence growth in the near future.

U.S. Medical Image Analysis Software Market size, by modality, 2020 - 2030 (USD Million)

The AI-based solutions have various applications in medical imaging including diagnosis, detection, image analysis, and clinical decision support. Though AI adoption is in the early phase in MRI and CT technologies, rising demand for accuracy, efficiency, and patient safety is anticipated to boost the adoption of AI-enabled medical imaging over the forecast period. The adoption of technologically advanced products, such as multimodality imaging platforms and 3D imaging, and benefits associated with the use of these systems, such as high-resolution imaging, convenient use, and flexibility, are contributing to the growing demand. The introduction of technologically advanced products and the advent of efficient information management systems are expected to drive market growth in the coming years.

Focus on innovation in medical image analysis has also given rise to certain measures that are being implemented.Furthermore, medical image processing can assist in disease diagnosis, treatment, and early detection. It has been regarded as one of the most cutting-edge technologies used to combat the COVID-19 crisis. In the context of COVID-19 disease, numerous AI, machine learning, and deep learning approaches have been used in medical image processing, which will further drive market growth.Diagnostic and research centers are expected to emerge as crucial end users of image analysis solutions owing to the rising demand for efficient solutions for better patient outcomes. These segments accounted for smaller revenue shares as they commonly outsource imaging services from hospitals.

Software Type Insights

Integrated software dominated the market in 2021 with a revenue share of more than 54.5%. This high share is attributed to the benefits associated with the use of these solutions. The integrated toolkit is designed for a host of radiology applications to improve workflow. For instance, Philip’s Xcelera Cardiology Information Management is an integrated image management software that facilitates single-point access to advanced clinical applications and improves clinical workflow. The introduction of these types of solutions is contributing to the segment’s dominant revenue share. High adoption of integrated systems due to its benefits, such as cost-effectiveness, centralized data storage, and access to live data for multiple users to process, is anticipated to further fuel the segment growth.

Stand-alone platforms are anticipated to witness a steady growth. These platforms are user-friendly and cost less as compared to integrated solutions. These solutions offer more details and features and are used by researchers, allowing them to share and access research data and analyses, thereby enhancing their ability to diagnose, research, monitor, and treat disorders. For instance, GE Healthcare’s ViewPoint 6 (for MFM) is a standalone software designed for dedicated ultrasound reporting and image management.

Modality Insights

On the basis of modalities, the global market has been further divided into tomography, ultrasound imaging, radiographic imaging, and combined modalities. The tomography segment accounted for the maximum share of 33.1% of the global revenue in 2021 owing to its cost-effectiveness. Dual-source and AI-enabled CT scanners are expected to be important milestones in the market growth. The introduction of advanced products is anticipated to propel the demand for CT imaging software in the coming years. For instance, ClariPiInc received FDA clearance for its AI-enabled CT scanner called “ClariCT.AI” in June 2019. Radiographic systems followed in terms of revenues.

Owing to the early introduction of radiography x-ray systems, the adoption of these instruments has increased over the years. Radiography involves the use of x-rays and as such, poses a related risk of harmful radiation through prolonged exposure. However, the benefits of radiography far exceed the risks posed by these procedures. The segment is expected to expand at a steady CAGR over the forecast period.The ultrasound image analysis software segment is anticipated to witness the fastest CAGR during the forecast years due to benefits, such as rapid analysis and accuracy. In addition, ultrasound imaging is non-invasive and there is no ionizing radiation exposure associated with it. This is a major factor driving the segment growth.

Imaging Type Insights

The 4D imaging segment accounted for the largest market share of more than 45.00% in 2021. This segment is expected to maintain its leading position throughout the forecast period owing to technological advancements in 4D imaging technology enabling efficient and accurate real-time visualization of the human body, thereby eliminating distortion in procedures. 4D imaging is a 3-dimensional image analysis with real-time movement. The 3D and 4D imaging software solutions markets are likely to experience lucrative growth rates during the forecast period owing to the increasing adoption of these technologies.

In addition, shifting focus to provide enhanced care has led to the incorporation of various computer-aided diagnosis systems, which is further contributing to the market growth. The introduction of technologically advanced products and multimodality imaging platforms is also expected to drive the demand for the software in the coming years. For instance, in April 2021, the U.S. FDA granted 510(k) clearance to Philips’ SmartCT 3D imaging software.

Application Insights

The cardiology segment accounted for the maximumshare of more than 20.00% of the global revenue in 2021. The growth is attributed to the high prevalence of cardiovascular and congenital heart diseases and government support to improve the accessibility of treatments. In February 2020, the U.S. FDA approved marketing of software to help medical professionals in the acquisition of echocardiography or cardiac ultrasound, images. The software, known as Caption Guidance, is an addition to compatible diagnostic ultrasound systems and utilizes artificial intelligence to help the user capture a patient’s heart images that are of normal diagnostic quality.

The oncology and mammography segments are anticipated to witness significant growth in the coming years as the prevalence of cancer is increasing at an alarming rate. This is likely to result in a growing demand for diagnostic solutions over the forecast period. According to a study conducted by the American College of Surgeons Clinical Congress, surgeons are focusing on advancing computer technologies to improve the visualization of cancerous tumors. This is anticipated to boost the adoption of these software solutions in the years to come.

End-use Insights

On the basis of end uses, the global market has been segmented into hospitals, diagnostic centers, Ambulatory Surgical Centers (ASCs), and others. The hospitals segment accounted for the largest revenue share of more than 36.00% in 2021 and will remain dominant throughout the forecast period. One of the key factors aiding the segment growth is supportive infrastructure, which is crucial in performing surgical interventions using medical imaging software. Compared to research and diagnostic centers, the installed base of diagnostic imaging systems and solutions is higher in hospitals. In addition, patient inflow is also relatively much higher. This continues to keep the end-use segment in the lead.

Global Medical Image Analysis Software Market share, by end use, 2021 (%)

Moreover, favorable reimbursement initiatives by governments around the world have resulted in greater surgery volumes, thereby boosting demand. The growing healthcare costs are a major concern plaguing the healthcare sector and it comes the fact that not many patients can afford the treatment they need, including surgical procedures. This has required healthcare providers to come up with new ways to make such services more reasonable while concentrating on quality. ASCs have proven to be an effective solution in these scenarios. Hence the ASC segment is expected to grow at the fastest CAGR during the forecast period.

Regional Insights

North America dominated the market in 2021 and accounted for the largest share of more than 37.00% of the global revenue. This growth is attributed to the presence of well-established healthcare facilities with advanced diagnostic equipment and favorable government initiatives to support the adoption of healthcare IT in this region. In addition, increasing R&D investments and the presence of key market players are contributing to the regional market growth. MIM Software Inc. published a collaboration with GenesisCare, provider of integrated cancer care globally, to expand patient access on a global scale.

GenesisCare’s clinical teams treat over 400,000 patients at more than 440 locations for cancer treatment in Australia, U.S., U.K., and Spain. Hence such initiatives are expected to support the regional market growth. Asia Pacific is anticipated to exhibit the second-fastest CAGR over the forecastperiod owing to the increasing adoption of medical image analysis software by healthcare professionals in the region. The growing awareness about the associated benefits of these systems is a key factor expected to propel market growth. Furthermore, increasing healthcare expenditure and disposable income levels in countries, such as China and India, are contributing to the regionalmarket growth.

Key Companies & Market Share Insights

The industry is highly competitive with a handful of companies dominating the global market. The industry is technology-driven as there is continuous R&D being undertaken for the development of cost-effective diagnostic solutions. Competitors are adopting strategies, such as collaborative agreements, partnerships, mergers and acquisitions, regional expansions, and new product developments to gain an edge over the others. Some prominent players in the global medical image analysis software market are:

  • Toshiba Medical Systems Corp.

  • Bruker Corp.

  • Xinapse Systems Ltd.

  • Esaote, Inc.

  • ClaroNAv, Inc.

  • Merge Healthcare Inc.

  • Aquilab GmbH

  • Spacelabs Healthcare, Inc.

  • MIM Software Inc.

  • Carestream Health, Inc.

  • Agfa-Gevaert Corp.

  • Philips Healthcare

  • Siemens Healthineers

  • GE Healthcare 

Medical Image Analysis Software Market Report Scope

Report Attribute

Details

Market size value in 2022

USD 3.07 billion

Revenue forecast in 2030

USD 5.49 billion

Growth rate

CAGR of 7.5% from 2022 to 2030

Base year for estimation

2021

Historical data

2017 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million and CAGR from 2022 to 2030

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

Software type, modality, imaging type, application, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country Scope

U.S.; Canada; Germany; U.K.; France; Italy; Spain; Russia; Japan; China; India; South Korea; Australia; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE

Key companies profiled

Koninklijke Philips N.V.; GE Healthcare, Inc.; Siemens Healthineers; Agfa-Gevaert Group; Toshiba Medical Systems Corp. (Canon Medical Systems Corp.); Spacelabs Healthcare; MIM Software, Inc.; Aquilab SAS; ESAOTE SpA; Merge Healthcare, Inc. (IBM); ClaroNav, Inc.; Xinapse, Inc.; Bruker

Customization scope

Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global medical image analysis software market report on the software type, modality, imaging type, application, end use, and region:

  • Software Type Outlook (Revenue, USD Million, 2017 - 2030)

    • Integrated Software

    • Stand-alone Software

  • Modality Outlook (Revenue, USD Million, 2017 - 2030)

    • Tomography

      • Computed Tomography

      • Magnetic Resonance Imaging

      • Positron Emission Tomography

      • Single-Photon Emission Tomography

    • Ultrasound Imaging

    • Radiographic Imaging

    • Combined Modalities

  • Imaging Type Outlook (Revenue, USD Million, 2017 - 2030)

    • 2D Imaging

    • 3D Imaging

    • 4D Imaging

  • Application Outlook (Revenue, USD Million, 2017 - 2030)

    • Orthopedic

    • Dental

    • Neurology

    • Cardiology

    • Oncology

    • Obstetrics & Gynecology

    • Mammography

    • Urology & Nephrology

  • End-use Outlook (Revenue, USD Million, 2017 - 2030)

    • Hospitals

    • Diagnostic Centers

    • Ambulatory Surgical Centers (ASCs)

    • Others (Academic & Research Centers)

  • Regional Outlook (Revenue, USD Million, 2017 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Russia

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.